PT1183035E - Transplante de medula óssea para tratamento de acidente vascular cerebral - Google Patents

Transplante de medula óssea para tratamento de acidente vascular cerebral Download PDF

Info

Publication number
PT1183035E
PT1183035E PT00935910T PT00935910T PT1183035E PT 1183035 E PT1183035 E PT 1183035E PT 00935910 T PT00935910 T PT 00935910T PT 00935910 T PT00935910 T PT 00935910T PT 1183035 E PT1183035 E PT 1183035E
Authority
PT
Portugal
Prior art keywords
stroke
treatment
bone marrow
marrow transplantation
transplantation
Prior art date
Application number
PT00935910T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Ford Henry Health System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ford Henry Health System filed Critical Ford Henry Health System
Publication of PT1183035E publication Critical patent/PT1183035E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
PT00935910T 1999-05-14 2000-05-11 Transplante de medula óssea para tratamento de acidente vascular cerebral PT1183035E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13434499P 1999-05-14 1999-05-14

Publications (1)

Publication Number Publication Date
PT1183035E true PT1183035E (pt) 2015-03-04

Family

ID=22462927

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00935910T PT1183035E (pt) 1999-05-14 2000-05-11 Transplante de medula óssea para tratamento de acidente vascular cerebral

Country Status (9)

Country Link
US (1) US20090162327A1 (enExample)
EP (1) EP1183035B1 (enExample)
JP (1) JP2002544234A (enExample)
AU (1) AU780994B2 (enExample)
CA (1) CA2373808C (enExample)
DK (1) DK1183035T3 (enExample)
ES (1) ES2531592T3 (enExample)
PT (1) PT1183035E (enExample)
WO (1) WO2000069448A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653134B2 (en) * 1995-03-28 2003-11-25 Cp Hahnemann University Isolated stromal cells for use in the treatment of diseases of the central nervous system
US8017112B2 (en) 1999-05-14 2011-09-13 Henry Ford Health System Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases
US20050169896A1 (en) * 1999-05-14 2005-08-04 Henry Ford Health System Bone marrow transplantation for treatment of stroke
JP2003507349A (ja) * 1999-08-18 2003-02-25 ザ ゼネラル ホスピタル コーポレーション 中枢神経系への損傷からの回復を促進する方法、組成物およびキット
US6749850B1 (en) 1999-08-18 2004-06-15 The General Hospital Corporation Methods, compositions and kits for promoting recovery from damage to the central nervous system
WO2001075094A1 (en) * 2000-04-04 2001-10-11 Thomas Jefferson University Application of myeloid-origin cells to the nervous system
KR100947577B1 (ko) 2000-06-26 2010-03-15 엔씨 메디컬 리서치 가부시키가이샤 신경계 세포로 분화할 수 있는 세포를 포함하는 세포분획
ES2180433B1 (es) * 2001-05-28 2004-05-16 Universidad Miguel Hernandez De Elche. Empleo de celulas madre hematopoyeticas en la generacion de celulas madre neurales.
US9969980B2 (en) 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
WO2003038075A1 (en) * 2001-10-30 2003-05-08 Renomedix Institute Inc. Method of inducing differentiation of mesodermal stem cells, es cells or immortalized cells into nervous system cells
CN1638775A (zh) * 2002-01-04 2005-07-13 亨利福尔德健康组织 治疗疾病和损伤用的氧化氮供体
US7687505B2 (en) 2002-01-14 2010-03-30 Board Of Trustees Of The University Of Illinois Use of modified pyrimidine compounds to promote stem cell migration and proliferation
US9969977B2 (en) 2002-09-20 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
US20060210544A1 (en) 2003-06-27 2006-09-21 Renomedix Institute, Inc. Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient
KR101130220B1 (ko) * 2003-06-27 2012-04-13 엔씨 메디컬 리서치 가부시키가이샤 간엽계 세포를 유효 성분으로 하는 뇌신경 질환 치료용 체내 투여용 약제
RU2283121C2 (ru) * 2004-11-29 2006-09-10 Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН Способ лечения инсульта
US20080107632A1 (en) * 2006-09-06 2008-05-08 Henrich Cheng Fibrin glue composition for repairing nerve damage and methods thereof
WO2008156728A1 (en) 2007-06-15 2008-12-24 Neuronyx, Inc. Treatment of diseases and disorders using self-renewing colony forming cells cultured and expanded in vitro
JP5276816B2 (ja) * 2007-09-10 2013-08-28 肇 井上 神経機能改善剤
CA2753833A1 (en) * 2008-02-28 2009-09-03 Henry Ford Health System Compositions and methods for using stromal cells to enhance treatment of central nervous system injuries
CN105072914B (zh) * 2013-02-06 2018-09-21 Nc医学研究公司 用于治疗神经变性的细胞疗法
CN105814196A (zh) * 2013-10-14 2016-07-27 哈达斯特医疗研究服务和开发有限公司 终末分化的神经元谱系的获得方法及其用途
WO2015174087A1 (ja) * 2014-05-16 2015-11-19 公益財団法人先端医療振興財団 脳梗塞の予防及び／又は治療の為の医薬
RU2612981C1 (ru) * 2015-12-21 2017-03-14 Алексей Сергеевич Бывальцев Способ лечения ишемического инсульта
US11464804B1 (en) 2017-11-15 2022-10-11 Enrico Stazzone Intrathecal multifactorial infusion of heterogeneous autologous cell therapy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666828A (en) * 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) * 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5272057A (en) * 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) * 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5612211A (en) * 1990-06-08 1997-03-18 New York University Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
US5851832A (en) * 1991-07-08 1998-12-22 Neurospheres, Ltd. In vitro growth and proliferation of multipotent neural stem cells and their progeny
US5750376A (en) * 1991-07-08 1998-05-12 Neurospheres Holdings Ltd. In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny
CA2159738A1 (en) * 1993-04-13 1994-10-27 Eugene O. Major Use of neuro-derived fetal cell lines for transplantation therapy
US6653134B2 (en) * 1995-03-28 2003-11-25 Cp Hahnemann University Isolated stromal cells for use in the treatment of diseases of the central nervous system
AU3888699A (en) * 1998-05-07 1999-11-23 University Of South Florida Bone marrow cells as a source of neurons for brain and spinal cord repair
GB9904281D0 (en) * 1999-02-24 1999-04-21 Reneuron Ltd Transplantation

Also Published As

Publication number Publication date
US20090162327A1 (en) 2009-06-25
CA2373808C (en) 2011-04-19
EP1183035A4 (en) 2003-05-07
AU5130000A (en) 2000-12-05
AU780994B2 (en) 2005-04-28
EP1183035B1 (en) 2014-12-03
CA2373808A1 (en) 2000-11-23
EP1183035A1 (en) 2002-03-06
DK1183035T3 (en) 2015-03-09
ES2531592T3 (es) 2015-03-17
WO2000069448A1 (en) 2000-11-23
JP2002544234A (ja) 2002-12-24

Similar Documents

Publication Publication Date Title
PT1183035E (pt) Transplante de medula óssea para tratamento de acidente vascular cerebral
IL160923A0 (en) Bone fixation system
AU2000257674A1 (en) Bone marrow biopsy needle
DE59907286D1 (de) Marknagel zur Knochendistraktion
PT1066838E (pt) Composição para a regeneração de tecidos ósseos
AU2002353044A8 (en) System and method for bone fixation
ZA995980B (en) Reduction forceps for long bone fractures.
AU2001259154A1 (en) Bone fixation system
SG86377A1 (en) Method of sterilization
HUP0202853A3 (en) Use of retigabin for treating neuropathic pain
AU5204300A (en) Bone plate for osteosynthesis
AU2002321889A1 (en) Devices and method for extraction of bone marrow
AU7015301A (en) Osteogenic implants derived from bone
AU4704196A (en) Enhancing bone marrow engraftment using mscs
GB2355051B (en) Strain-inducing conical screw for stimulating bone transplant growth
GB9920785D0 (en) Bone splint
EP1215963A4 (en) METHOD FOR THE TREATMENT OF NEUROPATHIC PAIN USING HETEROARYLMETHANSULFONAMIDES
AU3904200A (en) Bone fracture fixation clip
AU6245898A (en) Injectable formulations for treatment of osteoporotic bone
GB9928837D0 (en) Novel bone cement
IL132078A0 (en) Bone marrow as a site for transplantation
EP1513404A4 (en) INTRAMYOCARDIAL INJECTIONS OF AUTOLOGOUS BONE MARROW
HUP0001890A3 (en) Tissue structure for transplantation surgery
AU2002364941A8 (en) Engineered bone marrow
PL349786A1 (en) Bone stimulating factor